Concepedia

Author

Lynn Chamberlain

Howard Hughes Medical Institute

Also Known As

Lynn Chamberlain

15

Publications

527

Citations

7

H-Index

22

Concepts

All Affiliations

Howard Hughes Medical InstituteUniversity of Massachusetts Chan Medical SchoolYale University
LC

About

Lynn Chamberlain is an author at Howard Hughes Medical Institute specializing in medicine, cell biology, and cancer genetics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

337

2

Cell Biology

3

3

337

3

Natural Sciences

2

2

310

4

Immunology

1

1

27

5

Molecular Biology

1

1

128

Lynn Chamberlain

×

7

Publications

525

Citations

7

H-Index

YearCitations

TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein

Sanchita Bhatnagar, Claude Gazin, Lynn Chamberlain,

Nature

2014

182

U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3′ End Formation

Sung Mi Park, Jianhong Ou, Lynn Chamberlain,

Molecular Cell

2016

128

Genetic and pharmacological reactivation of the mammalian inactive X chromosome

Sanchita Bhatnagar, Xiaochun Zhu, Jianhong Ou,

Proceedings of the National Academy of Sciences

2014

96

Non-canonical TAF complexes regulate active promoters in human embryonic stem cells

Glenn A. Maston, Lihua Julie Zhu, Lynn Chamberlain,

eLife

2012

42

Analysis of Gal4-directed transcription activation using Tra1 mutants selectively defective for interaction with Gal4

Ling Lin, Lynn Chamberlain, Lihua Julie Zhu,

Proceedings of the National Academy of Sciences

2012

31

The CREB Coactivator CRTC2 Is a Lymphoma Tumor Suppressor that Preserves Genome Integrity through Transcription of DNA Mismatch Repair Genes

Minggang Fang, Magnolia L. Pak, Lynn Chamberlain,

Cell Reports

2015

27

A Large-Scale RNAi-Based Mouse Tumorigenesis Screen Identifies New Lung Cancer Tumor Suppressors That Repress FGFR Signaling

Ling Lin, Lynn Chamberlain, Magnolia L. Pak,

Cancer Discovery

2014

19

Page 1